单期与多阶段腔内修复广泛胸腹主动脉瘤的系统综述与荟萃分析
该系统综述与荟萃分析比较单期与多阶段开窗分支腔内修复(FB-EVAR)治疗广泛胸腹主动脉瘤(TAAA)的效果,纳入4项队列研究共1949例患者,其中1097例(56.28%)接受多阶段修复。多阶段修复显著降低永久性脊髓损伤(OR 0.37;95%CI 0.23-0.58;P<.0001)、任何脊髓损伤(OR 0.51;95%CI 0.29-0.93;P=.03)、30天或住院死亡率(OR 0.57;95%CI 0.38-0.85;P=.006)及急性肾损伤风险(OR 0.67;95%CI 0.51-0.89;P=.005),心脏、脑血管或肠道并发症无显著差异。
要点
- 多阶段FB-EVAR显著降低永久性脊髓损伤(OR 0.37;95%CI 0.23-0.58;P<.0001)。
- 多阶段FB-EVAR显著降低30天或住院死亡率(OR 0.57;95%CI 0.38-0.85;P=.006)。
- 多阶段FB-EVAR显著降低急性肾损伤风险(OR 0.67;95%CI 0.51-0.89;P=.005)。
核心结论
- 多阶段FB-EVAR用于择期广泛TAAA修复显著降低永久性和任何脊髓损伤事件、30天或住院死亡率及急性肾损伤风险。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase和Cochrane数据库自建库至2024年3月,注册于PROSPERO(CRD42024567099),遵循PRISMA指南。
- 纳入4项比较单期与多阶段FB-EVAR治疗广泛TAAA(Crawford/Safi I-III和V型)的原始队列研究,共1949例择期FB-EVAR患者。
主要发现
- 多阶段修复组1097例(56.28%),最常用的分期策略为胸主动脉腔内修复,共404例(37%)。
- 多阶段修复显著降低永久性脊髓损伤(OR 0.37;95%CI 0.23-0.58;P<.0001)和任何脊髓损伤(OR 0.51;95%CI 0.29-0.93;P=.03)。
- 多阶段修复显著降低30天或住院死亡率(OR 0.57;95%CI 0.38-0.85;P=.006)和急性肾损伤风险(OR 0.67;95%CI 0.51-0.89;P=.005)。
- 心脏、脑血管或肠道并发症在单期与多阶段修复间无显著差异。
关键数值与推荐
- 多阶段修复定义:除FB-EVAR外,采用一种或多种分期策略行动脉瘤隔绝,包括暂时性瘤囊灌注、一期胸主动脉腔内修复、非计划开放手术或腔内近端胸主动脉修复、以及微创分期节段动脉弹簧圈栓塞。
- 广泛TAAA定义为Crawford/Safi I-III和V型。
- 采用随机效应荟萃分析,合并比值比(OR)及95%置信区间(CI)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to perform a systematic review and meta-analysis comparing the outcomes of single-stage vs multistaged fenestrated-branched endovascular aortic repair (FB-EVAR) for extensive thoracoabdominal aortic aneurysms (TAAAs). METHODS: MEDLINE, Embase, and Cochrane databases were searched from inception to March 2024. This study was registered in PROSPERO (CRD42024567099) and followed the PRISMA guidelines. Inclusion was restricted to original studies comparing single-stage vs multistaged FB-EVAR for reported patients evaluated as extensive TAAAs (Crawford/Safi extent I-III and V). A multistaged approach consisted of aneurysm exclusion besides FB-EVAR using one or more staging strategies, including temporary aneurysm sac perfusion, first stage thoracic endovascular aortic repair, unintentional open surgical or endovascular proximal thoracic aortic repair, and minimally invasive staged segmental artery coil embolization. Endpoints evaluated included permanent and any spinal cord injury (SCI), 30-day or in-hospital mortality, acute kidney injury, cardiac, cerebrovascular, and bowel complications. A random effects meta-analysis was performed using pooled odds ratios (ORs) with 95% confidence intervals (CIs). RESULTS: Four cohort studies involving 1949 patients treated by elective FB-EVAR were included, including 1097 patients (56.28%) treated by the multistaged approach. The most frequently used staging strategy was thoracic endovascular aortic repair in 404 patients (37%). Multistaged repairs significantly reduced permanent SCI events (OR, 0.37; 95% CI, 0.23-0.58; P < .0001), any SCI events (OR, 0.51; 95% CI, 0.29-0.93; P = .03), and 30-day or in-hospital mortality (OR, 0.57; 95% CI, 0.38-0.85; P = .006). Additionally, the multistaged approach was associated with lower risk of acute kidney injury (OR, 0.67; 95% CI, 0.51-0.89; P = .005), although there were no significant differences observed for cardiac, cerebrovascular, or bowel complications. CONCLUSIONS: Multistaged FB-EVAR for elective extensive TAAA repair significantly reduces the risks of permanent and any SCI events, 30-day or in-hospital mortality, and acute kidney injury.
引用
- Godeiro Fernandez M, Pimentel-Junior D, Dias-Neto M, et al. A systematic review and meta-analysis comparing single-stage versus multistaged approaches for endovascular repair of extensive thoracoabdominal aortic aneurysms. J Vasc Surg. 2025. PMID: 40054789. doi:10.1016/j.jvs.2025.01.234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。